These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30867076)

  • 1. Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
    Steen NE; Dieset I; Hope S; Vedal TSJ; Smeland OB; Matson W; Kaddurah-Daouk R; Agartz I; Melle I; Djurovic S; Jönsson EG; Bogdanov M; Andreassen OA
    Psychol Med; 2020 Mar; 50(4):595-606. PubMed ID: 30867076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Cwik M; Walkup J; Weis S
    Neurochem Int; 2008 May; 52(6):1297-303. PubMed ID: 18328600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kynurenine pathway in schizophrenia and bipolar disorder.
    Erhardt S; Schwieler L; Imbeault S; Engberg G
    Neuropharmacology; 2017 Jan; 112(Pt B):297-306. PubMed ID: 27245499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.
    Condray R; Dougherty GG; Keshavan MS; Reddy RD; Haas GL; Montrose DM; Matson WR; McEvoy J; Kaddurah-Daouk R; Yao JK
    Int J Neuropsychopharmacol; 2011 Jul; 14(6):756-67. PubMed ID: 21275080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.
    Miller CL; Llenos IC; Dulay JR; Weis S
    Brain Res; 2006 Feb; 1073-1074():25-37. PubMed ID: 16448631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum kynurenic acid is reduced in affective psychosis.
    Wurfel BE; Drevets WC; Bliss SA; McMillin JR; Suzuki H; Ford BN; Morris HM; Teague TK; Dantzer R; Savitz JB
    Transl Psychiatry; 2017 May; 7(5):e1115. PubMed ID: 28463241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.
    Myint AM; Schwarz MJ; Verkerk R; Mueller HH; Zach J; Scharpé S; Steinbusch HW; Leonard BE; Kim YK
    Brain Behav Immun; 2011 Nov; 25(8):1576-81. PubMed ID: 21620952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics in patients with psychosis: A systematic review.
    Li C; Wang A; Wang C; Ramamurthy J; Zhang E; Guadagno E; Trakadis Y
    Am J Med Genet B Neuropsychiatr Genet; 2018 Sep; 177(6):580-588. PubMed ID: 30076730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kynurenines in pathogenesis of endogenous psychiatric disorders].
    Shilov IuE; Bezrukov MV
    Vestn Ross Akad Med Nauk; 2013; (1):35-41. PubMed ID: 23805637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kynurenine pathway in psychosis: evidence of increased tryptophan degradation.
    Barry S; Clarke G; Scully P; Dinan TG
    J Psychopharmacol; 2009 May; 23(3):287-94. PubMed ID: 18562404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain
    Skorobogatov K; De Picker L; Verkerk R; Coppens V; Leboyer M; Müller N; Morrens M
    Front Immunol; 2021; 12():716980. PubMed ID: 34630391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tryptophan breakdown and cognition in bipolar disorder.
    Platzer M; Dalkner N; Fellendorf FT; Birner A; Bengesser SA; Queissner R; Kainzbauer N; Pilz R; Herzog-Eberhard S; Hamm C; Hörmanseder C; Maget A; Rauch P; Mangge H; Fuchs D; Zelzer S; Schütze G; Moll N; Schwarz MJ; Mansur RB; McIntyre RS; Reininghaus EZ
    Psychoneuroendocrinology; 2017 Jul; 81():144-150. PubMed ID: 28482311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The KMO allele encoding Arg452 is associated with psychotic features in bipolar disorder type 1, and with increased CSF KYNA level and reduced KMO expression.
    Lavebratt C; Olsson S; Backlund L; Frisén L; Sellgren C; Priebe L; Nikamo P; Träskman-Bendz L; Cichon S; Vawter MP; Osby U; Engberg G; Landén M; Erhardt S; Schalling M
    Mol Psychiatry; 2014 Mar; 19(3):334-41. PubMed ID: 23459468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered interactions of tryptophan metabolites in first-episode neuroleptic-naive patients with schizophrenia.
    Yao JK; Dougherty GG; Reddy RD; Keshavan MS; Montrose DM; Matson WR; Rozen S; Krishnan RR; McEvoy J; Kaddurah-Daouk R
    Mol Psychiatry; 2010 Sep; 15(9):938-53. PubMed ID: 19401681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
    Ney DM; Murali SG; Stroup BM; Nair N; Sawin EA; Rohr F; Levy HL
    Mol Genet Metab; 2017 Jun; 121(2):96-103. PubMed ID: 28400091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tryptophan breakdown pathway in bipolar mania.
    Myint AM; Kim YK; Verkerk R; Park SH; Scharpé S; Steinbusch HW; Leonard BE
    J Affect Disord; 2007 Sep; 102(1-3):65-72. PubMed ID: 17270276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two complex genotypes relevant to the kynurenine pathway and melanotropin function show association with schizophrenia and bipolar disorder.
    Miller CL; Murakami P; Ruczinski I; Ross RG; Sinkus M; Sullivan B; Leonard S
    Schizophr Res; 2009 Sep; 113(2-3):259-67. PubMed ID: 19502010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of inflammation on the kynurenine pathway in schizophrenia - a systematic review.
    Pedraz-Petrozzi B; Elyamany O; Rummel C; Mulert C
    J Neuroinflammation; 2020 Feb; 17(1):56. PubMed ID: 32061259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder.
    van den Ameele S; van Nuijs AL; Lai FY; Schuermans J; Verkerk R; van Diermen L; Coppens V; Fransen E; de Boer P; Timmers M; Sabbe B; Morrens M
    Bipolar Disord; 2020 Feb; 22(1):59-69. PubMed ID: 31398273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine.
    Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H
    J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.